IHF vs. IHE
IHF (iShares U.S. Healthcare Providers ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds from iShares - IHF tracks the Dow Jones U.S. Select Health Care Providers Index while IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index. Both are passively managed. Over the past 10 years, IHF returned 8.88%/yr vs 8.99%/yr for IHE. A 0.63 correlation means they provide meaningful diversification when combined. IHF charges 0.43%/yr vs 0.42%/yr for IHE.
Performance
IHF vs. IHE - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with IHF having a 11.55% return and IHE slightly higher at 11.65%. Both investments have delivered pretty close results over the past 10 years, with IHF having a 8.88% annualized return and IHE not far ahead at 8.99%.
IHF
- 1D
- 0.74%
- 1M
- 5.23%
- YTD
- 11.55%
- 6M
- 12.02%
- 1Y
- 14.30%
- 3Y*
- 2.85%
- 5Y*
- 0.85%
- 10Y*
- 8.88%
IHE
- 1D
- 1.60%
- 1M
- 3.16%
- YTD
- 11.65%
- 6M
- 10.97%
- 1Y
- 46.87%
- 3Y*
- 18.43%
- 5Y*
- 10.55%
- 10Y*
- 8.99%
IHF vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IHF iShares U.S. Healthcare Providers ETF | 11.55% | 0.92% | -7.90% | -1.11% | -7.11% | 24.46% | 17.67% | 22.34% | 9.56% | 25.45% |
IHE iShares U.S. Pharmaceuticals ETF | 11.65% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
Correlation
The correlation between IHF and IHE is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.41 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.53 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.57 |
Correlation (All Time) Calculated using the full available price history since May 5, 2006 | 0.63 |
Over the past year, the correlation between IHF and IHE has dropped to 0.31 - well below their long-term average of 0.63, suggesting their price drivers have been diverging.
IHF vs. IHE - Sectors Allocation Comparison
Sectors
IHF
IHE
Healthcare
Financial Services
-
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
IHF
IHE
Financial Services
IHF
IHE
-
Technology
IHF
IHE
-
Basic Materials
IHF
-
IHE
-
Communication Services
IHF
-
IHE
-
Consumer Cyclical
IHF
-
IHE
-
Consumer Defensive
IHF
-
IHE
-
Energy
IHF
-
IHE
-
Industrials
IHF
-
IHE
-
Real Estate
IHF
-
IHE
-
Utilities
IHF
-
IHE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHF vs. IHE — Risk / Return Rank
IHF
IHE
IHF vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Healthcare Providers ETF (IHF) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IHF | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.08 | ||
| Sortino ratioReturn per unit of downside risk | -2.99 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 1.46 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | 0.73 | 5.56 | -4.83 |
| Martin ratioReturn relative to average drawdown | 1.68 | 17.09 | -15.41 |
Loading charts...
Drawdowns
IHF vs. IHE - Drawdown Comparison
The maximum IHF drawdown since its inception was -58.42%, which is greater than IHE's maximum drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for IHF and IHE.
Loading charts...
Drawdown Indicators
| IHF | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.42% | -38.20% | -20.22% |
Max Drawdown (1Y)Largest decline over 1 year | -19.72% | -8.47% | -11.25% |
Max Drawdown (3Y)Largest decline over 3 years | -29.85% | -15.92% | -13.93% |
Max Drawdown (5Y)Largest decline over 5 years | -29.85% | -16.03% | -13.82% |
Max Drawdown (10Y)Largest decline over 10 years | -35.23% | -29.59% | -5.64% |
Current DrawdownCurrent decline from peak | -7.44% | -0.70% | -6.74% |
Average DrawdownAverage peak-to-trough decline | -10.64% | -7.90% | -2.74% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.51% | 2.75% | +5.76% |
Volatility
IHF vs. IHE - Volatility Comparison
iShares U.S. Healthcare Providers ETF (IHF) and iShares U.S. Pharmaceuticals ETF (IHE) have volatilities of 5.27% and 5.27%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IHF | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.27% | 5.27% | 0.00% |
Volatility (6M)Calculated over the trailing 6-month period | 16.10% | 12.68% | +3.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.90% | 17.22% | +4.68% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.17% | 16.28% | +2.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.02% | 18.05% | +2.97% |
IHF vs. IHE - Expense Ratio Comparison
IHF has a 0.43% expense ratio, which is higher than IHE's 0.42% expense ratio.
Dividends
IHF vs. IHE - Dividend Comparison
IHF's dividend yield for the trailing twelve months is around 0.98%, less than IHE's 1.56% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.56% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
IHF iShares U.S. Healthcare Providers ETF | 0.98% | 1.05% | 0.86% | 0.79% | 0.74% | 0.56% | 0.53% | 0.58% | 4.01% | 0.19% | 0.25% | 0.20% |
Frequently Asked Questions
IHF and IHE have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHE has higher volatility (5.27%) compared to IHF (5.27%). In terms of maximum drawdown, IHF dropped -58.42% vs IHE's -38.20%.
On 10-year performance, IHE leads with 8.99% vs 8.88% for IHF. On fees, IHE is cheaper at 0.42% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IHE has performed better with a 8.99% return vs 8.88%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHE is cheaper with a 0.42% expense ratio, compared with 0.43% for IHF.
IHE has the higher dividend yield at 1.56%, compared with 0.98% for IHF.
IHF tracks Dow Jones U.S. Select Health Care Providers Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. Their fees differ too: 0.43% for IHF and 0.42% for IHE.
IHE currently has the higher Sharpe Ratio (2.74 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IHF and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer